Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis - Sainz-Cort A, Mart ín-Islas M, Ona G, Jiménez-Garrido D, López-Navarro M, Muñoz-Marron E, Viejo-Sobera R, Bouso JC.
Cannabis is being legalized for medical and recreational purposes all around the world. However, the understanding of the psychological effects of cannabis is still limited, and it has been previously linked to mental disorders such as schizophrenia. Latel... (Source: SafetyLit)
Source: SafetyLit - November 22, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Copy number variation analysis of aggressive behaviour in schizophrenia - De Luca V, Chaudhary Z, Al-Chalabi N, Qian J, Xu X, Gerretsen P, Bani-Fatemi A, Simpson A, Fischer C, Graff A, Kolla NJ.
INTRODUCTION: An increased proclivity towards violence is often associated with those diagnosed with schizophrenia (SCZ), despite contradictory findings from prior studies exploring the association between violence and SCZ. Evidence has shown that certain ... (Source: SafetyLit)
Source: SafetyLit - November 22, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism'
(MedPage Today) -- Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the FDA for an indication in schizophrenia.
A Massachusetts... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 22, 2023 Category: Psychiatry Source Type: news
Neuromelanin-Sensitive MRI Linked to Psychosis Severity in Schizophrenia
MONDAY, Nov. 20, 2023 -- Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) contrast is associated with psychosis severity in antipsychotic-free patients with schizophrenia, according to a study published online Nov. 8 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2023 Category: Pharmaceuticals Source Type: news
Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - a multicenter cross-sectional study - B öge K, Hallford DJ, Pillny M.
The precise nature of the relationship between mindfulness, psychological flexibility (PF) and psychopathology in schizophrenia spectrum disorders (SSD) remains largely unclear and warrants further investigation. We recruited 43 persons with SSD and 43 con... (Source: SafetyLit)
Source: SafetyLit - November 20, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
A randomized, prospective, active-controlled study comparing intramuscular long-acting paliperidone palmitate versus oral antipsychotics in patients with schizophrenia at risk of violent behavior - Wang G, Huang H, Wang Y, Yang Y, Li C, Luo S, Li Y.
This study aims to explore the effects of long-te... (Source: SafetyLit)
Source: SafetyLit - November 18, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Association between suicidal ideation and cognitive function in young patients with schizophrenia spectrum disorder - Kim JS, Baek SH, Kim H, Kim JW, Kang HJ, Ryu S, Lee JY, Kim JM, Kim SW.
INTRODUCTION: Suicide is a major concern for patients with recent-onset schizophrenia. We hypothesized that preserved cognitive function might be associated with a higher level of suicidality in patients with schizophrenia. We investigated the associations... (Source: SafetyLit)
Source: SafetyLit - November 18, 2023 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
New Treatment Modality May Reduce Obesity in Schizophrenia Patients
FRIDAY, Nov. 17, 2023 -- In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin.
Dongyu Kang, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2023 Category: Pharmaceuticals Source Type: news
Childhood emotional maltreatment increases the "wear-and-tear" of physiological systems, especially neuroendocrine changes in schizophrenia - Xu S, Xu L.
[The publisher has not provided an abstract for this article.]
Language: en... (Source: SafetyLit)
Source: SafetyLit - November 8, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Smoking cannabis can make you more empathetic, according to a new study
It's got a bad rap recently - said to cause heart attacks and schizophrenia. But a new study shows using cannabis can make you a more empathetic person. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2023 Category: Consumer Health News Source Type: news
Construction and verification of aggressive behavior risk prediction model in stable patients with schizophrenia - Sun Y, Jiang W, Yu H, Zhang J, Zhou Y, Yin F, Su H, Jia Y.
BACKGROUND: Among all types of mental disorders, individuals with schizophrenia exhibit the highest frequency of aggressive behavior. This disrupts the healthcare environment and poses threats to family life and social harmony. Present approaches fail to i... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia - Kim HK, Gon çalves VF, Husain MI, Müller DJ, Mulsant BH, Zai G, Kloiber S.
In this study, we explored DNA variations in the ECS across major depressive disorder (MDD), bipolar disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum dis... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Cannabis use and suicide in non-affective psychosis: a mini-review of recent literature - Ricci V, Cristofori E, Passarello E, Paggi A, Cavallo A, Ceci F, Martinotti G, De Berardis D, Maina G.
Proof of correlation between psychotic spectrum disorders and suicide are found in literature, as well as between cannabis use disorder (CUD) and suicide and between CUD and schizophrenia. The study population of the selected papers consists of subjects di... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Evaluation of sex hormone levels in schizophrenia and depressive disorder - Kili ç N, Kuloğlu MM, Ustundag B.
In this study, we aimed to evaluate the levels of FSH, LH, estradiol, testosterone, progesterone, and prolactin in patients with schizophrenia and maj ör depressive disorder. Material and Method: Our study included a total of 80 female patients d... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Phase III Win in Schizophrenia; Bipolar Blood Test; How Do Psychedelics Work?
(MedPage Today) -- The 50-mg dose of the investigational drug brilaroxazine significantly reduced symptoms of schizophrenia in adults within 4 weeks in the phase III RECOVER trial, developer Reviva Pharmaceuticals announced.
Severe mental illness... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - November 1, 2023 Category: Psychiatry Source Type: news
